Heba K. Nabih

Possible Role of microRNA-122 in Modulating Multidrug Resistance of Hepatocellular Carcinoma

Shaymaa M.M. Yahya, Shadia A. Fathy, Zakaria El-Khayat et al. · Indian Journal of Clinical Biochemistry · 2017 · 39 citations · Full text

Medicine, Molecular Biology, Oncology +16

The diagnostic significance of circulating miRNAs and metabolite profiling in early prediction of breast cancer in Egyptian women

Safinaz E. El-Toukhy, Sherien M. El‐Daly, Mahmoud M. Kamel et al. · Journal of Cancer Research and Clinical Oncology · 2022 · 19 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Anti-drug resistance, anti-inflammation, and anti-proliferation activities mediated by melatonin in doxorubicin-resistant hepatocellular carcinoma: in vitro investigations

Ahmed R. Hamed, Shaymaa M.M. Yahya, Heba K. Nabih · Naunyn-Schmiedeberg s Archives of Pharmacology · 2023 · 19 citations · Full text

Medicine, Oncology, Pharmacology +17

Restoring microRNA-34a overcomes acquired drug resistance and disease progression in human breast cancer cell lines via suppressing the ABCC1 gene

Shaymaa M.M. Yahya, Heba K. Nabih, Ghada H. Elsayed et al. · Breast Cancer Research and Treatment · 2023 · 19 citations · Full text

Medicine, Bioinformatics, Oncology +17

Anti-proliferative effect of melatonin in human hepatoma HepG2 cells occurs mainly through cell cycle arrest and inflammation inhibition

Heba K. Nabih, Ahmed R. Hamed, Shaymaa M.M. Yahya · Scientific Reports · 2023 · 13 citations · Full text

Medicine, Oncology, Pharmacology +13